Glenmark
Pharma stocks rally 14% on US tariff exemption; Gland, Aurobindo Pharma lead gains
Domestic formulations biz expected to grow 9-10% over next decade: Glenmark
Glenmark unit ties up with BeiGene to market cancer drugs in India
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg)
/newsdrum-in/media/media_files/azCgaLHqDbWb0p4Zoycn.jpg)
/newsdrum-in/media/media_files/sensex-nifty-share-market-stock-market.jpg)
/newsdrum-in/media/media_files/mNfyx1tZqtFuxLZeTYcf.jpg)
/newsdrum-in/media/media_files/kzvct5LDfyHTShdSzB4P.jpg)
/newsdrum-in/media/media_files/azCgaLHqDbWb0p4Zoycn.jpg)
/newsdrum-in/media/media_files/Up3K4xjPqc97rriLFIXB.jpg)
/newsdrum-in/media/media_files/44VzbdVu1RTy4PAjniQg.jpg)
/newsdrum-in/media/post_banners/1H2spcMiSzRPtD7GH27Y.jpg)
